Status:
COMPLETED
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
Lead Sponsor:
Alcon Research
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.
Eligibility Criteria
Inclusion
- Adults with a clinical diagnosis of ocular hypertension, or primary open-angle, pigment dispersion or exfoliation glaucoma in at least one eye (study eye)
Exclusion
- Age
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2007
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00444665
Start Date
May 1 2007
End Date
August 1 2007
Last Update
November 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fridley
Fridley, Minnesota, United States, 55432